Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis
Crossref DOI link: https://doi.org/10.1007/s10096-017-2976-x
Published Online: 2017-04-08
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cetinkaya, M.
Oral, T. K.
Karatekin, S.
Cebeci, B.
Babayigit, A.
Yesil, Y.
License valid from 2017-04-08